Introduction

Case 1
Human immunodeficiency virus-associated nephropathy (HIVAN ) was first recognized in the early 1980s
A 32-year-old HIV-positive man presented in January as a separate clinical entity [1] . Histologically, the 1995 with gross proteinuria of 11.97 g/l (normal condition resembles focal and segmental glomerulorange, NR<0.06 g/l ) and a plasma albumin concentrasclerosis (FSGS ); patients presenting with gross protion of 11 g/l (NR 35-53 g/l ). Plasma urea (NR teinuria and rapidly progressive renal failure often 3.0-8.0 mmol/l ) and creatinine (NR 50-125 mmol/l ) develop end-stage renal disease in a few weeks or concentrations were 6 mmol/l and 143 mmol/l, respectmonths. The condition is more common in those of ively. Histology of renal biopsy tissue showed a mixed African origin [2] and in those whose HIV status is immune-complex glomerulonephritis with a predomithe result of intravenous drug abuse. Evidence suggests nantly membranous pattern, associated with interstitial that the condition may be due to a direct effect of the nephritis, and which was similar to that seen in systemic HIV virus on the kidney. lupus erythematosus ( Figure 1 ). He was started iniOther renal lesions occurring in HIV-positive tially on prednisolone and the angiotensin converting patients are membranous glomerulonephritis (MGN ) enzyme inhibitor (ACEI ) enalapril. Gradually over the [3] (including a form that is similar to lupus nephritis succeeding months his urine protein concentration fell [4] ), IgA nephropathy [4, 5] , haemolytic uraemic synto 5.95 g/l and his plasma albumin concentration rose drome (HUS) [2] , and immune-complex-mediated to 23 g/l. glomerulonephritis in patients with co-existent hepatitis In March 1996 he was started on anti-retroviral C infection [6 ] . therapy with two NRTIs, zidovudine and lamivudine. No effective treatment has been found and the His pre-treatment CD4 count was 60×106/l and majority of patients with HIVAN become dialysisplasma HIV RNA level, 38 520 copies/ml (Roche PCR dependent. Trials of high-dose oral prednisolone have assay). By September 1996 he was still nephrotic with had some success in reversing the effects of both a plasma albumin concentration of 20 g/l. In early HIVAN [7] and MGN [3] , as has treatment with the 1997, although his urinary protein loss had begun to nucleoside analogue reverse transcriptase inhibitor fall, his plasma creatinine concentration had risen to (NRTI ), zidovudine [8] . However, no single treatment a peak of 239 mmol/l; a repeat renal biopsy in May has proven effective in reversing, or stabilizing, renal 1997 still showed a lupus-like membranous glomerulofailure in HIV-positive patients.
nephritis, but with fewer immune complex deposits. We describe two cases of male HIV-positive patients His 24-h urine protein excretion was 7 g and his plasma who presented with the nephrotic syndrome and had albumin concentration 32 g/l. membranous glomerulonephritis on renal biopsy (Brief In early 1997 it was evident that he was failing to preliminary clinical and pathological details of these respond to his antiretroviral therapy. His plasma HIV cases have been reported elsewhere [9] was cotrimoxazole for prophylaxis against and mesangial cells directly [10] 
); his plasma albumin concentration factor b (TGFb). In vitro, high levels of TGFb are is currently 42 g/l, and his plasma urea and creatinine produced by peripheral blood mononuclear cells concentrations are 8.7 mmol/l and 149 mmol/l, respect-infected by HIV, inhibiting T-cell stimulation and ively. His CD4 cell count is 270×106/l and his HIV down-regulating the ability of CD4 cells to proliferate viral load is undetectable (<500 copies/ml to DNA).
in response to infection [11, 12] . Viral load also seems to be an important factor in determining the degree of proteinuria and renal failure.
Case 2
A study in 1995 by Kimmel et al. [13] found that in HIV-positive patients on haemodialysis, there was a A 34-year-old man with chronic hepatitis B infection higher incidence of measurable plasma viraemia than and who was diagnosed HIV-positive in 1986, pre-in HIV-positive individuals with no evidence of renal sented in April 1994 with proteinuria of 4.56 g/24-h disease, or in those with chronic renal failure, but not and a plasma albumin concentration of 24 g/l, having on dialysis. There was no correlation between the been 35 g/l the previous year. His plasma urea severity of renal impairment and the CD4 cell count. and creatinine concentrations were 3.4 mmol/l and It is likely that the improvement in proteinuria in 105 mmol/l, respectively. Renal biopsy tissue showed our two patients is a direct effect of the more potent membranous glomerulopathy with patchy sparing of antiviral activity of a PI-containing regimen. In case 1, the glomerular basement membrane and focal inter-although there was some improvement with dual NRTI stitial nephritis. An ultrasound scan of his kidneys and therapy, further improvement occurred only when bladder was normal. He was given the ACEI enalapril, better suppression of plasma HIV RNA levels was which reduced his proteinuria to below the nephrotic achieved using a PI-based regimen. In case 2, although range (1.6 g/24-h), but he remained hypoalbuminaemic plasma HIV levels have remained detectable, they have (28 g/l ). By June 1995 he had progressed to full blown remained at low levels for over 2 years. AIDS with cryptosporridial diarrhoea and a CD4 count
Triple combination regimens containing a PI are of only 60×106/l. He was treated briefly with zidovud-now part of the standard treatment of HIV infection ine monotherapy, but he was unable to tolerate it [14] . Unless there is an additional effect of a PI that because of nausea and anaemia.
is independent of its antiviral activity, it is likely that In March 1996 he was started on the PI indinavir other combination regimens without a PI will be as and the NRTI stavudine. His pre-treatment CD4 count effective in the treatment of HIV-associated renal diswas 20×106/l, his plasma albumin concentration 34 g/l ease. This, and our own observations, will need to be and his plasma creatinine concentration 113 mmol/l. evaluated in future studies. The stavudine was substituted for lamivudine in
We cannot necessarily extend these results to other December 1996, because he developed a peripheral causes of proteinuria, particularly the more widespread neuropathy. He sustained a good immunological and FSGS-like lesion, and controlled clinical trials are clinical response to this therapeutic combination. After necessary. A note of caution must be sounded, how-2 years of antiretroviral therapy he has only trace ever, because there is growing evidence that PIs have proteinuria on dipstick testing, a plasma albumin con-important adverse side effects, including hyperlipidaecentration of 44 g/l, a plasma creatinine concentration mia [15] (also a feature of the nephrotic syndrome), of 99 mmol/l and a stable CD4 count of 290×106/l. lipodystrophy [16] [17] [18] , insulin resistance [16 ] , nephroThroughout therapy his plasma HIV RNA level calcinosis and even acute renal failure [19] . has remained detectable, though low, at <10 000
If the response to treatment of our two patients with copies/ml. protease inhibitors proves to be typical of HIV-induced proteinuria, this form of therapy will not only reduce the morbidity and mortality in these patients, but it
Discussion
will also relieve a potentially increasing burden on many dialysis units. Until now, life expectancy of HIVIn both the cases described, substantial improvements positive patients receiving both haemodialysis and periin the degree of proteinuria and plasma albumin contoneal dialysis has been poor when compared with centration were seen after treatment of their HIV non-infected dialysis patients. There is also the continuinfection with a PI-containing combination drug regiing risk of exposure of dialysis staff to infection, both men. Therapy also resulted in a significant and susthrough regular venepuncture on haemodialysis units tained rise in CD4 counts and a fall in plasma HIV and from peritoneal dialysate. If protease inhibitors RNA level.
can ameliorate the nephrotic syndrome and renal failThe mechanisms by which HIV induces the nephrotic ure in HIV-positive patients, this will significantly syndrome and concomitant renal failure in patients improve their quality of life and life expectancy, and with such a variety of histological renal lesions are not perhaps also the need for dialysis and its associated fully understood. Laboratory and clinical evidence suggests that the virus infects glomerular endothelial risks to both patients and staff.
